Summit Partners Public Asset Management »

Castle Biosciences shares owned by Summit Partners Public Asset Management

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by Summit Partners Public Asset Management from 13F filings

Historical chart of Summit Partners Public Asset Management investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by Summit Partners Public Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by Summit Partners Public Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.1M 400k 22.77

More positions owned by Summit Partners Public Asset Management

Spotify Technology S A SHS (SPOT)
Insmed Com Par $.01 Call Option (INSM)
Verona Pharma Sponsored Ads (VRNA)
NVIDIA Corporation Call Option (NVDA)
Sandisk Corp (SNDK)
Ge Vernova (GEV)
Microsoft Corporation (MSFT)
Carvana Cl A Call Option (CVNA)
Solaris Energy Infras Com Cl A Put Option (SEI)
Mongodb Cl A Put Option (MDB)
Rubrik Cl A (RBRK)
Genedx Holdings Corp Com Cl A (WGS)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
MKS Instruments Call Option (MKSI)
Astera Labs (ALAB)

View all positions for Summit Partners Public Asset Management

Top funds holding Castle Biosciences

BlackRock
Vanguard Group
Principal Financial Group
Portolan Capital Management
Dimensional Fund Advisors
Nuveen
Braidwell
State Street Corporation
AIGH Capital Management
Geode Capital Management
Daniel D. Thurber
Allianz Asset Management
Palisade Capital Management
Millennium Management
Renaissance Technologies

View all funds holding Castle Biosciences